Cite
HARVARD Citation
Lakeman, I. et al. (2019). Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families. Journal of medical genetics. 56 (9), pp. 581-589. [Online].